Cargando…

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications

Spondyloarthritis and inflammatory bowel diseases are chronic immune disorders of the joints and the gut that often coexist in the same patient, increasing the burden of each disorder, worsening patients’ quality of life, and influencing therapeutic strategies. Genetic predisposition, environmental...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felice, Carla, Dal Buono, Arianna, Gabbiadini, Roberto, Rattazzi, Marcello, Armuzzi, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968229/ https://www.ncbi.nlm.nih.gov/pubmed/36835369 http://dx.doi.org/10.3390/ijms24043957

Ejemplares similares

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023)

Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano
por: Bartocci, Bianca, et al.
Publicado: (2023)

Technological advances in inflammatory bowel disease endoscopy and histology
por: Alfarone, Ludovico, et al.
Publicado: (2022)

Ileal Pouch–Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy
por: Gabbiadini, Roberto, et al.
Publicado: (2022)

Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections
por: Cavalli, Carolina Aliai Micol, et al.
Publicado: (2023)

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management
por: Terrin, Maria, et al.
Publicado: (2023)

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?
por: Furfaro, Federica, et al.
Publicado: (2021)

Endoscopic Surveillance in Inflammatory Bowel Diseases: Selecting a Suitable Technology
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?
por: Solitano, Virginia, et al.
Publicado: (2023)

Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in Therapy
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art
por: Vespa, Edoardo, et al.
Publicado: (2022)

Cytokines and integrins related to inflammation of joint and gut in patients with spondyloarthritis and inflammatory bowel disease
por: Kontny, Ewa, et al.
Publicado: (2017)

Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention
por: Sewell, Gavin W, et al.
Publicado: (2022)

Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease
por: Guan, Qingdong, et al.
Publicado: (2017)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Understanding the Pathogenesis of Spondyloarthritis
por: Sharip, Aigul, et al.
Publicado: (2020)

Frontiers in Drug Research and Development for Inflammatory Bowel Disease
por: Currò, Diego, et al.
Publicado: (2017)

Joint Disease Activity in Inflammatory Bowel Disease–associated Peripheral Spondyloarthritis Stratifies Therapeutic Response
por: LAI, D., et al.
Publicado: (2022)

Update on the management of inflammatory bowel disease: specific role of adalimumab
por: Guidi, Luisa, et al.
Publicado: (2011)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

Cytokine profiles in axial spondyloarthritis
por: Madej, Marta, et al.
Publicado: (2015)

Ultrasound Elastography in Inflammatory Bowel Diseases: A Systematic Review of Accuracy Compared with Histopathological Assessment
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Blood Pressure Variability and Therapeutic Implications in Hypertension and Cardiovascular Diseases
por: Nardin, Chiara, et al.
Publicado: (2019)

Inflammatory Cytokines in Psoriatic Arthritis: Understanding Pathogenesis and Implications for Treatment
por: Lee, Bong-Woo, et al.
Publicado: (2023)

Inflammatory Bowel Disease-related Spondyloarthritis: The Last Unexplored Territory of Rheumatology
por: Zioga, Nikoleta, et al.
Publicado: (2022)

Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review
por: Dal Buono, Arianna, et al.
Publicado: (2021)

Natalizumab in Crohn's disease: past and future areas of applicability
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta-Analysis
por: Grossi, Ugo, et al.
Publicado: (2022)

Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
por: Rizzello, Fernando, et al.
Publicado: (2018)

BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management
por: Marzo-Ortega, Helena, et al.
Publicado: (2020)

Obesity, Lipid Profile and Cytokines in Spondyloarthritis
por: Slouma, Maroua, et al.
Publicado: (2022)

Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease
por: Malaty, Hoda M, et al.
Publicado: (2017)

Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs
por: Benfaremo, Devis, et al.
Publicado: (2019)

The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients
por: Huseynzada, Sinakhanım, et al.
Publicado: (2023)

Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question
por: Gabbiadini, Roberto, et al.
Publicado: (2022)

Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies
por: Armuzzi, Alessandro, et al.
Publicado: (2019)

The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_35o4j71c0uguk4ladflppmdn5o